deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT01608490

Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study (RENEW)

Sponsor: Boston Scientific Corporation

Conditions Emphysema
Interventions RePneu Lung Volume Reduction Coil System
Updated 15 times since 2017 Last updated: Jul 15, 2021 Started: Oct 31, 2012 Primary completion: Dec 31, 2015 Completion: Jul 26, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

FDA approval of supplementation to IDE to terminate subject long term follow up

Other terminated trials from Boston Scientific Corporation

More terminations from Boston Scientific Corporation

Other Emphysema trials with similar outcome

Browse all Emphysema trials

A NA clinical study on Emphysema, this trial is terminated or withdrawn. The trial is conducted by Boston Scientific Corporation and has accumulated 15 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshot~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Sep 2019 · 12 months · monthly snapshot~Sep 2019 – ~Jan 2021 · 16 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshot~Sep 2021 – ~Dec 2022 · 15 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated NA

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated NA

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  4. Jan 2023 — Jul 2024 [monthly]

    Terminated NA

  5. Dec 2022 — Jan 2023 [monthly]

    Terminated NA

▶ Show 10 earlier versions

  1. Sep 2021 — Dec 2022 [monthly]

    Terminated NA

  2. Apr 2021 — Sep 2021 [monthly]

    Terminated NA

  3. Mar 2021 — Apr 2021 [monthly]

    Terminated NA

  4. Jan 2021 — Mar 2021 [monthly]

    Terminated NA

  5. Sep 2019 — Jan 2021 [monthly]

    Terminated NA

    Status: Active Not Recruiting → Terminated

  6. Sep 2018 — Sep 2019 [monthly]

    Active Not Recruiting NA

  7. Jun 2018 — Sep 2018 [monthly]

    Active Not Recruiting NA

  8. Aug 2017 — Jun 2018 [monthly]

    Active Not Recruiting NA

    Phase: PHASE3 → NA

  9. Feb 2017 — Aug 2017 [monthly]

    Active Not Recruiting PHASE3

  10. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boston Scientific Corporation
  • PneumRx, Inc.
Data source: Boston Scientific Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Baltimore, United States , Birmingham, United States , Boston, United States , Charleston, United States , Chicago, United States , Cleveland, United States , Denver, United States , Durham, United States , Gainesville, United States and 18 more locations